Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018–2023
Jonathan Sobel(University Hospital of Geneva), Olivia Keiser(University of Geneva), Anne Iten(University Hospital of Geneva), Davide Bosetti(University Hospital of Geneva), Peter W. Schreiber(University Hospital of Zurich), Rami Sommerstein(University of Bern), Alexia Cusini(Spital Thurgau (Switzerland)), Ulrich Heininger(University Children’s Hospital Basel), Anita Niederer-Loher(Ostschweizer Kinderspital), Camille B. Valera(University of Geneva), Rebecca Grant(University Hospital of Geneva), M. Süveges(University of Geneva), Marie-Céline Zanella(University of Geneva), Petra Zimmermann(University of Fribourg), Khaled Mostaguir(SIB Swiss Institute of Bioinformatics), Philipp Jent(University of Bern), Laura Urbini(University of Geneva), Didier Pittet(University Hospital of Geneva), Stéphan Harbarth(World Health Organization), Sara Botero Mesa(University of Geneva), Ursina Roder(Federal Office of Public Health), Domenica Flury
Cited by 0
Related Papers
ExPASy: SIB bioinformatics resource portal
|Nucleic Acids Research|2012|2.4k
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857
Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections
|Archives of Disease in Childhood|2020|534
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
|British Journal of Cancer|2010|301